 | Up a level |
Maugans, C, Loveday, M, Hlangu, S, Waitt, C 
ORCID: 0000-0003-0134-5855, Van Schalkwyk, M, van de Water, B, Salazar-Austin, N, McKenna, L, Mathad, JS, Kalk, E et al (show 5 more authors)
(2023)
Best practices for the care of pregnant people living with TB.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 27 (5).
pp. 357-366.
Perez Nicholas, O, Lamorde, M, Kintu, K, Wang, D, Chen, T, Malaba, T, Myer, L, Waitt, C, Reynolds, H ORCID: 0000-0001-7443-4520 and Khoo, S
(2020)
COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM.
.
Orrell, C, Kintu, K, Coombs, JA, Amara, A, Myer, L, Kaboggoza, J ORCID: 0000-0001-9510-0474, Simmons, B, Else, L, Heiberg, C, Waitt, C et al (show 5 more authors)
(2018)
DolPHIN-1: Randomised controlled trial of dolutegravir (DTG)- versus efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late pregnancy.
.
Hawcutt, DB ORCID: 0000-0002-8120-6507, Russell, NJ, Maqsood, H, Kouranloo, K, Gomberg, S, Waitt, C ORCID: 0000-0003-0134-5855, Sharp, A ORCID: 0000-0003-3396-7464, Riordan, A and Turner, MA ORCID: 0000-0002-5299-8656
(2016)
Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis.
British journal of clinical pharmacology, 82 (06).
pp. 1601-1612.